BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9644114)

  • 21. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
    Zinkham WH; Kickler T; Borel J; Moser HW
    N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipoid pneumonia as a complication of Lorenzo's oil therapy in a patient with adrenoleukodystrophy.
    Majori M; Scarascia A; Anghinolfi M; Pisi R; Gnetti L; Casalini AG
    J Bronchology Interv Pulmonol; 2014 Jul; 21(3):271-3. PubMed ID: 24992138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More on Lorenzo's oil.
    Odone A; Odone M
    N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
    [No Abstract]   [Full Text] [Related]  

  • 25. A happier sequel to Lorenzo's Oil?
    Wanders RJ
    Nat Med; 1998 Nov; 4(11):1245-6. PubMed ID: 9809546
    [No Abstract]   [Full Text] [Related]  

  • 26. Lorenzo's oil and lymphocytopenia.
    Unkrig CJ; Schröder R; Scharf RE
    N Engl J Med; 1994 Feb; 330(8):577. PubMed ID: 8204158
    [No Abstract]   [Full Text] [Related]  

  • 27. Normal natural killer cell activity in a patient with adrenoleukodystrophy treated with Lorenzo's oil.
    Tanaka M; Koike R; Kuwabara T
    Neurodegeneration; 1996 Jun; 5(2):192-4. PubMed ID: 8819141
    [No Abstract]   [Full Text] [Related]  

  • 28. Lorenzo's oil--hope and disappointment.
    Rizzo WB
    N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
    [No Abstract]   [Full Text] [Related]  

  • 29. Dietary management of X-linked adrenoleukodystrophy.
    Moser HW; Borel J
    Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive effects with Lorenzo's oil.
    Siva N
    Lancet Neurol; 2005 Sep; 4(9):529. PubMed ID: 16136703
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adrenoleukodystrophy: Lorenzo's Oil].
    Yamawaki T
    Brain Nerve; 2022 Dec; 74(12):1354-1357. PubMed ID: 36503132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy].
    Söderfeldt B
    Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombocytopenia associated with use of Lorenzo's oil.
    Chai BC; Siminoski K
    Am J Hematol; 1993 Dec; 44(4):290-1. PubMed ID: 8238006
    [No Abstract]   [Full Text] [Related]  

  • 34. Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil.
    Sedlmayr P; Plecko B; Paschke E; Zenz W; Ramschak H; Toplak H; Wascher TC; Wilders-Truschnig M; Stöckler S
    J Inherit Metab Dis; 1995; 18(1):101-2. PubMed ID: 7623436
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.
    Pour RB; Stöckler-Ipsiroglu S; Hunneman DH; Gahr M; Korenke GC; Pabst W; Hanefeld F; Peters A
    J Inherit Metab Dis; 2000 Mar; 23(2):113-9. PubMed ID: 10801052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenoleukodystrophy and the mitochondrial connection: clues for supplementing Lorenzo's oil.
    Moraes CT
    Brain; 2013 Aug; 136(Pt 8):2339-41. PubMed ID: 23842565
    [No Abstract]   [Full Text] [Related]  

  • 37. A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers.
    Cappa M; Bizzarri C; Petroni A; Carta G; Cordeddu L; Valeriani M; Vollono C; De Pasquale L; Blasevich M; Banni S
    J Inherit Metab Dis; 2012 Sep; 35(5):899-907. PubMed ID: 22189598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
    Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
    Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
    [No Abstract]   [Full Text] [Related]  

  • 40. Improvement of clinical and MRI findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy.
    Maeda K; Suzuki Y; Yajima S; Asano J; Yamaguchi S; Matsumoto N; Borel J; Moser HW; Orii T
    Brain Dev; 1992 Nov; 14(6):409-12. PubMed ID: 1492654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.